Stay on the Cutting Edge of Biotech, MedTech, and Pharma

Discover healthcare innovations with expert insights, in-depth articles, and cutting-edge research. Stay informed with BioMed Nexus.

Recent Posts:

Biotech

20 Biotech Startups to Watch in 2025

Biotechnology is advancing rapidly, driving innovation across healthcare, agriculture, food, and manufacturing. At the forefront of these advancements are gene editing technologies like CRISPR/Cas9, which enable precise modifications to the genetic code of living organisms. This technology holds promise for treating genetic disorders and enhancing agricultural productivity. Meanwhile, synthetic biology is enabling the design of new biological systems and molecules, facilitating developments in pharmaceuticals, biofuels,

Funding

Hatteras Venture Partners Raises Over $200 Million for Life Sciences Startups

Durham-based VC firm closes largest funding round amid sector downturn, marking 25 years and 100th portfolio investment Hatteras Venture Partners has closed two investment funds with a total of $200 million in commitments, announced Wednesday morning, representing the firm’s largest fundraising to date and a

MedTech

Alcon Acquires STAAR Surgical for $1.5 Billion to Expand Vision Care Portfolio

Strategic deal adds premium implantable lens technology at 51% premium to strengthen refractive surgery position Alcon announced its agreement to acquire STAAR Surgical for approximately $1.5 billion in an all-cash transaction valued at $28 per share, representing a 51% premium that sent STAAR shares soaring

Biotech

The Great Biotech Reset: Why 20+ Companies Cut Jobs in August as Industry Faces New Reality

August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its most dramatic restructuring in over a decade. From industry giants like CSL Limited cutting 1,700 jobs to startups slashing 85%

Biotech

Global Biotech Trends Highlight Approvals, Deals, and Health Alerts

Sector evolution marked by breakthrough approvals, billion-dollar transactions, and emerging health challenges Recent global biotech developments showcase the sector’s dynamic nature, with breakthrough drug approvals, major acquisition activity, and responses to emerging disease outbreaks demonstrating the industry’s critical role in global health. The convergence of

Funding

Multiple Biotechs Raise Capital on August 12

Sector-wide fundraising activity reflects continued capital needs across biotech industry August 12 marked a particularly active day for biotech fundraising, with companies including 180 Life Sciences, Aditxt, Entero, Equillium, Ligand, Longeveron, Ocugen, and Xortx all reporting various forms of capital raising activity. This coordinated financing

Funding

Hatteras Venture Partners Raises Over $200 Million for Life Sciences Startups

MedTech

Alcon Acquires STAAR Surgical for $1.5 Billion to Expand Vision Care Portfolio

MedTech

FDA Grants Clearance to Nyxoah’s Genio Sleep Apnea Device

The FDA has granted clearance to Nyxoah’s innovative Genio system, a breakthrough hypoglossal nerve stimulation device designed to treat obstructive sleep apnea. This regulatory approval marks a significant milestone in sleep medicine, offering patients a new minimally invasive treatment option that could transform care for

Biotech

The Great Biotech Reset: Why 20+ Companies Cut Jobs in August as Industry Faces New Reality

FDA Approvals

FDA Suspends World’s First Chikungunya Vaccine After It Started Causing the Disease It Was Meant to Prevent

In a dramatic reversal that highlights the delicate balance of vaccine development, the FDA has suspended use of the world’s first chikungunya vaccine after recipients began developing the very disease the shot was designed to prevent. The decision to pull Valneva’s Ixchiq vaccine comes just

Healthcare Technology

UK’s Biggest Diabetes Care Shake-Up in a Decade: NICE Proposes Revolutionary Treatment Guidelines That Could Save 22,000 Lives

The UK’s National Institute for Health and Care Excellence (NICE) has proposed the most significant overhaul of type 2 diabetes treatment in over a decade, potentially revolutionizing care for millions of patients and preventing thousands of deaths. The draft guidelines represent a dramatic shift from

Stay on the Cutting Edge of Biotech, MedTech, and Pharma

Recent Posts:

20 Biotech Startups to Watch in 2025

Hatteras Venture Partners Raises Over $200 Million for Life Sciences Startups

Alcon Acquires STAAR Surgical for $1.5 Billion to Expand Vision Care Portfolio

Be the first to know about new posts

Biotech

The Great Biotech Reset: Why 20+ Companies Cut Jobs in August as Industry Faces New Reality

Global Biotech Trends Highlight Approvals, Deals, and Health Alerts

Multiple Biotechs Raise Capital on August 12

Medtech

Hatteras Venture Partners Raises Over $200 Million for Life Sciences Startups

Alcon Acquires STAAR Surgical for $1.5 Billion to Expand Vision Care Portfolio

FDA Grants Clearance to Nyxoah’s Genio Sleep Apnea Device

Pharma

The Great Biotech Reset: Why 20+ Companies Cut Jobs in August as Industry Faces New Reality

FDA Suspends World’s First Chikungunya Vaccine After It Started Causing the Disease It Was Meant to Prevent

UK’s Biggest Diabetes Care Shake-Up in a Decade: NICE Proposes Revolutionary Treatment Guidelines That Could Save 22,000 Lives

#BioMedNexus

Stay on the Cutting Edge of Biotech, MedTech, and Pharma

Recent Posts:

Be the first to know about new posts

Biotech

Medtech

Pharma

#BioMedNexus

Join a Community of 35,000+ Industry Leaders and Innovators

Stay Ahead in Biotech & MedTech Innovations

Join the BioMed Nexus community and get the latest breakthroughs, research updates, and industry insights delivered straight to your inbox.